No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Combination of spartalizumab plus dabrafenib and trametinib does not significantly improve survival in BRAFV600-mutated metastatic melanoma

byTeddy Guo

July 27, 2022

in StudyGraphics

Reading Time: 1 min read

Religious and spiritual practices may improve mental health in older adults

RelatedReports

Significant reduction in prostate screening rates after revised guidelines

Chronic Disease

BRAFV600-mutant ctDNA as a Prognostic Biomarker in Resected Stage III Melanoma

April 28, 2025

Rapid growth of medical artificial intelligence technology usage identified from insurance claims analysis, yet major barriers to widespread adoption remain

Chronic Disease

Remibrutinib alleviates symptoms in chronic spontaneous urticaria resistant to H1-antihistamines

March 13, 2025

“No Evidence of Disease Activity” may be useful goal in multiple sclerosis

Chronic Disease

Ipilimumab/Nivolumab versus Nivolumab in Melanoma Brain Metastases

February 24, 2025

Increased risk of subsequent melanoma after first melanoma diagnosis

Dermatology

Neoadjuvant ipilimumab plus nivolumab improves event-free survival in stage III melanoma

December 12, 2024

Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma

Topical hypericin photodynamic therapy is effective and safe in early-stage T cell lymphoma

Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Intravenous tenecteplase non-inferior to alteplase for thrombolysis in acute ischemic stroke

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Long‐term outcomes of pulmonary vein isolation in patients with Brugada Syndrome and paroxysmal atrial fibrillation

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Combination of spartalizumab plus dabrafenib and trametinib does not significantly improve survival in BRAFV600-mutated metastatic melanoma

RELATED REPORTS

Religious and spiritual practices may improve mental health in older adults

Topical hypericin photodynamic therapy is effective and safe in early-stage T cell lymphoma

RelatedReports

Recent Reports